The London Technology team advised ExpressionEdits on its $13 million seed fundraise.
The funding round was co-led by Octopus Ventures and redalpine, with participation from BlueYard Capital, Wilbe Capital, Acequia Capital, Amino Collective, and Hawktail.
Founded in 2021 by Dr. Kärt Tomberg, Professor Allan Bradley, and Dr. Liliana Antunes based on research from the University of Cambridge, ExpressionEdits’ proprietary intronization technology, revolutionizes gene design by mimicking the natural genetic landscape. By strategically incorporating multiple short noncoding DNA sequences known as introns into artificial genes, ExpressionEdits has achieved significant enhancements in gene expression which leads to better protein production.
The deal team consisted of Ali Ramadan, Maria Dragun and George Fagan.
For additional details on the financing, please read ExpressionEdits’ press release.